scispace - formally typeset
D

David S. Weiss

Researcher at Emory University

Publications -  142
Citations -  16860

David S. Weiss is an academic researcher from Emory University. The author has contributed to research in topics: Virulence & Innate immune system. The author has an hindex of 38, co-authored 108 publications receiving 14104 citations. Previous affiliations of David S. Weiss include New York University & Yerkes National Primate Research Center.

Papers
More filters
Journal ArticleDOI

Neutrophil extracellular traps kill bacteria

TL;DR: It is described that, upon activation, neutrophils release granule proteins and chromatin that together form extracellular fibers that bind Gram-positive and -negative bacteria, which degrade virulence factors and kill bacteria.
Journal ArticleDOI

Cryopyrin activates the inflammasome in response to toxins and ATP

TL;DR: It is shown that cryopyrin-deficient macrophages cannot activate caspase-1 in response to Toll-like receptor agonists plus ATP, the latter activating the P2X7 receptor to decrease intracellular K+ levels.
Journal ArticleDOI

The apoptotic signaling pathway activated by Toll-like receptor-2.

TL;DR: It is shown that caspase activation is an innate immune response to microbial pathogens, culminating in apoptosis and cytokine production, and that TLR2 is a novel ‘death receptor’ that engages the apoptotic machinery without a conventional cytoplasmic death domain.
Journal ArticleDOI

Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis

TL;DR: It is shown that wild-type Francisella, which reach the cytosol, but not Francisella mutants that remain localized to the vacuole, induced a host defense response in macrophages, which is dependent on caspase-1 and the death-fold containing adaptor protein ASC, demonstrating a key role in innate defense against infection by this pathogen.
Journal ArticleDOI

A CRISPR/Cas system mediates bacterial innate immune evasion and virulence

TL;DR: It is demonstrated that the Cas protein Cas9 of Francisella novicida uses a unique, small, CRISPR/Cas-associated RNA (scaRNA) to repress an endogenous transcript encoding a bacterial lipoprotein.